Central nervous system lymphoma: Approach to diagnosis and treatment Review


Authors: Correia, C. E.; Schaff, L. R.; Grommes, C.
Review Title: Central nervous system lymphoma: Approach to diagnosis and treatment
Abstract: Central nervous system lymphoma (CNSL) is a rare form of extranodal non-Hodgkin lymphoma. Central nervous system lymphoma can be primary (isolated to the central nervous space) or secondary in the setting of systemic disease. Treatment of CNSL has improved since the introduction of high-dose methotrexate and aggressive consolidation regimens. However, results after treatment are durable in only half of patients, and long-term survivors may experience late neurotoxicity, impacting quality of life. Given the rarity of this disease, few randomized prospective trials exist. This leaves many questions unanswered regarding optimal first-line and salvage treatments. Recent advances in the knowledge of pathophysiology of CNSL will hopefully help the development of future treatments. This review gives an overview of the epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment of immunocompetent patients with CNSL.
Journal Title: The Cancer Journal
Volume: 26
Issue: 3
ISSN: 1528-9117
Publisher: Lippincott Williams & Wilkins  
Date Published: 2020-05-01
Start Page: 241
End Page: 252
Language: English
DOI: 10.1097/ppo.0000000000000449
PUBMED: 32496457
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 July 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christian Grommes
    150 Grommes
  2. Lauren Rhea Schaff
    57 Schaff